Lately, the single-cell RNAseq of ALS microglia evidenced a molecular signature of the disease driven by the triggering receptor expressed on myeloid cells 2 (TREM2), defined as disease-associated microglia (DAM) [3]. This evidence concerns the gene TREM2 and amyotrophic lateral sclerosis.